SUMMARY Jejunal biopsies from controls and coeliac patients were maintained in organ culture in the presence of gluten fraction III. The culture media were assayed for evidence of lymphokine activity in a migration inhibition test using normal peripheral blood leucocytes. Significant inhibition of migration was produced by media from untreated coeliac patients compared with controls (P<O.005) or treated coeliac patients (P<0.001), indicating the production of a leucocyte migration inhibition factor (LIF) by untreated coeliac mucosa in response to gluten fraction III. The degree of inhibition correlated with the preculture interepithelial lymphocyte count in the coeliac biopsies (P<0.02). In six coeliac patients studied when on a normal diet and on a gluten-free diet, LIF was produced while on a normal diet, but not while on a gluten-free diet. These results suggest that a local cell-mediated immune reaction to gluten is present in the mucosa of patients with untreated coeliac disease but that this is reversed by treatment with a gluten-free diet.
The mechanism by which gluten produces its toxic effect in coeliac disease is unknown. There is, however, considerable evidence of both humoral and cell-mediated immunity to gluten in coeliac patients.' Immunity to gluten may therefore be involved in the production of the characteristic mucosal lesion in coeliac disease. There is much evidence that cell-mediated immunity to gluten may be involved in this pathogenetic process. Ferguson and Murray2 showed that untreated coeliac mucosa was abnormally infiltrated with lymphocytes and this has been amply confirmed. There is evidence that interepithelial lymphocytes of the human gastrointestinal tract are T cells.3 Leucocyte migration inhibition in coeliac patients in response to various gluten fractions has provided evidence of lymphokine production by peripheral blood lymphocytes.4-7 However, more evidence is needed ofa cell-mediated mechanism within coeliac mucosa. In a preliminary communication in 1975, Ferguson et al.8 suggested that there are lymphocytes sensitised to a-gliadin in untreated but not in treated coeliac mucosa.
*This work was presented in part to the British Society of Gastroenterology, Spring Meeting, Hull, 1979. tAddress for reprint requests: Dr P D Howdle, University Department of Medicine, St James's University Hospital, Leeds 9. Received for publication 25 July 1981 We set out to confirm and extend this initial report with regard to treated and untreated patients, and to determine whether treatment with a glutenfree diet could reverse the abnormality in individual patients. The The culture medium consisted of Trowell's T8 medium (6 ml) , NCTC 135 medium (2 ml), glutamine 200 mM (0.2 ml), 1M Hepes buffer (0. 1 ml) (all obtained from Flow Laboratories Ltd, Ayrshire, Scotland), 1000 U penicillin (0.1 ml), 1000 U streptomycin (0. 1 ml), and fetal calf serum (1.5 ml) (Wellcome Research Laboratories, Beckenham).8 This medium (the 'control medium') was mixed one to two hours before use in the organ culture system, and kept at 37°C until the biopsies were obtained.
Gluten-containing medium was similarly constituted with the inclusion of 1 mg/ml of gluten fraction III (GFIII)'0 prepared from gluten (BDH Chemical Co. Ltd, Poole, UK).
Casein-containing medium was constituted by the inclusion in control medium of Leucocyte migration inhibition tests were performed on normal peripheral blood leucocytes from one of us. These leucocytes had previously been shown not to be inhibited by 1 mg/ml of GFIII.
Twenty millilitres of peripheral venous blood were defibrinated by shaking with glass beads and mixed with 10 ml dextran 150 in 0.9% saline under sterile conditions. After sedimentation for 30 minutes the leucocyte-rich supernate was centrifuged for 10 minutes at 1000 rpm. The cell pellet was resuspended in 10 ml medium 199 and recentrifuged for another 10 minutes at 1000 rpm. This washing procedure was repeated three times. The cell pellet was resuspended in medium 199 to give a packed cell volume of about 50%. The suspension was drawn into 20 gl capillary tubes (Drummond microcaps), which were heat sealed at one end, taking care not to char the cells. The cells were packed by centrifugation at 500 rpm for five minutes. Each capillary tube was cut squarely across just below the cell fluid interface and secured by silicone grease in Sterilin migration chambers which were rimmed with silicon grease. The chambers were filled with the organ culture medium, sealed with a coverslip, and incubated at 37°C for 20 hours.
Migration chambers were set up in quadruplicate and contained gluten-containing medium which had been used for organ culture, or control medium from the same patient which had been used for organ culture and then reconstituted with 1 mg/ml of GFIII. In six coeliac patients chambers were set up using the casein-containing medium or control medium reconstituted with casein.
After incubation the image of each migration chamber was projected on to a screen at constant magnification and the migration areas were traced out and measured by planimetry.
The migration index was calculated for each patient as the mean area of migration in gluten-(or casein) containing medium divided by the mean area of migration in control medium reconstituted with gluten (or casein) after culture.
The concentration of 1 mg/ml of GFIII used in these experiments was chosen, as we have previouslyshown that peripheral blood leucocytes from coeliac patients are sensitised to this concentration4 and also that coeliac mucosa shows in vitro sensitivity to this concentration."
INTER-EPITHELIAL LYMPHOCYTE COUNTS
These were performed on biopsies from all subjects obtained at the same time as those for organ culture but sent for routine histology. They were counted 'blind' by the method of Fig. 1 and Table 1 . The results are not significantly skewed and therefore parametric statistics were used to compare the data. The 95% confidence limits (mean ± 2 SD) were calculated for the control group and migration indices below 2 SD of the mean control value were taken to indicate significant inhibition.
In the 18 control patients there was no inhibition ofleucocyte migration as the mean migration index was 1.009. There was no significant difference between treated coeliac patients and controls, the mean migration index in treated coeliac patients being 1.023, and all indices in tieated coeliac patients fell within the 95% confidence limits ofthe control patients. There was significant inhibition in the untreated coeliac patients compared with controls (K<0.005) or treated coeliac patients (1<0.001). The mean migration index for untreated coeliac patients was 0.903 and seven patients (44%) showed indices below the 2 SD limit of the controls.
In Fig. 1 and Table 1 are contained the results from the three dermatitis herpetiformis patients, none of whom showed migration inhibition, and also from the Crohn's disease and tropical sprue patients, neither of whom showed inhibition.
HL-A typing was available in all coeliac patients and in 11 of the 18 normal control subjects. Migration indices were compared between B8 positive and B8 negative subjects within each group. The three dermatitis herpetiformis patients Interepithelial lymphocyte counts are shown in Fig. 2 and Table 1 . The counts are not significantly skewed and parametric statistics were used for comparison. The 95% confidence limits (mean ± 2 SD) in the controls were used to define the normal range in these patients.
There were significant differences in interepithelial lymphocyte counts between controls and both untreated and treated coeliac patients (p<0.001) and also between untreated and treated coeliac patients (1<0.001). There was no overlap between the control limits and those of the untreated coeliac patients. The range of controls was similar to that described by other authors.'4 Values from the abnormal controls were not included in the statistical calculations. As can be seen from Table 1 , the interepithelial lymphocyte count was raised in both the Crohn's patient and the patient with tropical sprue, but normal in all three patients with dermatitis herpetiformis.
The migration index was correlated with the preculture interepithelial lymphocyte count in all the coeliac patients (Fig. 3) . There was a low negative correlation (r= -0.40) which was, however, statistically significant (P<0.02).
Six of the coeliac patients were included in both untreated and treated coeliac groups, and thus paired data were available for these patients while taking a normal and also a gluten-free diet. The patient who initially had normal histology on a *em a The fifth patient was the one who developed abnormal histology after a normal diet for one month; the migration index was initially 0.936 and this decreased to 0.901 on a normal diet and might have decreased more if the patient had not then returned to a gluten-free diet. In one patient there was an initial migration index within the normal range. This fell on a gluten-free diet but still remained within the normal range. Figure 5 shows the interepithelial lymphocyte counts in biopsies from these same patients, taken while on a normal and a gluten-free diet. In every case the interepithelial lymphocyte count fell while on a gluten-free diet. gluten-free diet and who developed subtotal villous atrophy on a normal diet is included in these paired results. The results of the migration indices are shown in Fig. 4 . There is a significant increase in migration indices on a gluten-free diet compared with a normal diet (K<0.05). In five patients, the migration index increased when the patient was on a gluten-free diet. In four of these patients there was significant inhibition on a normal diet which returned to the normal range on a gluten-free diet.
This report confirms the findings in the preliminary communication of Ferguson et aL8 The results
show that a substance is produced by untreated coeliac mucosa in the presence of GFIII, which inhibits the migration of normal peripheral blood leucocytes, and that this abnormality can be reversed by treatment with a gluten-free diet. The inhibition of migration of peripheral blood leucocytes is generally taken to be an in vitro correlate of cell-mediated immunity. The substance producing migration inhibition is thought to be a lymphokine, leucocyte migration inhibitory factor (LIF), which is produced by sensitised lymphocytes on contact with their specific antigen. In the system used in this series of experiments it is believed that the lymphocytes sensitised to gluten are present in the coeliac mucosa and it is postulated that on exposure to GFIII in the organ culture system they release LIF into the culture medium. The presence of this LIF can then be assayed by its effect on the migration of normal leucocytes from capillary tubes. As expected, there was no LIF produced by any of the controls. Nor was it produced in the three patients with dermatitis herpetiformis, although this was not unexpected, as they had no evidence of in vivo gluten sensitivity; their jejunal biopsies were normal and the interepithelial lymphocyte counts were within the normal range. The patients with Crohn's disease and tropical sprue did not produce LIF, even though their interepithelial lymphocyte counts were raised and there was partial villous atrophy in the patient with tropical sprue, suggesting that abnormal mucosa in other diseases is not sensitised to gluten.
An inhibitory factor was produced by the untreated coeliac mucosa in the presence of GFIII. The patient marked E --0l was initially on a gluten-free diet and developed subtotal villous atrophy on a normal diet.
There is support for the specificity of gluten as the antigen, as casein did not stimulate the production of LIF in three untreated coeliac mucosae. However, it must be noted that, unfortunately, in only one of these three particular untreated coeliac mucosae did gluten stimulate the production of LIF.
If this inhibitory factor is produced by sensitised lymphocytes one might expect that there would be some correlation between the degree of inhibition that is, amount of LIF produced-and the interepithelial lymphocyte count. The results show that there is a significant correlation between these two The results show that, after treatment with a gluten-free diet, LIF is not produced in coeliac patients; in none of the treated patients was an LIF produced in the presence of gluten, nor, incidentally, in three patients in the presence of casein. Moreover, the change produced by a gluten-free diet is shown more specifically in the six patients who were studied on a normal and on a gluten-free diet. In five of these, inhibition on a normal diet was reversed by a gluten-free diet; in the sixth patient there was no inhibition on either diet. In these six patients it can also be seen that the interepithelial lymphocyte counts fell towards the normal range on a gluten-free diet.
Although the production of an LIF and the interepithelial lymphocyte count correlate, this is not evidence that they are causally related. The decrease in the LIF production and the fall in the interepithelial lymphocyte count on a gluten-free diet may both probably reflect the reversal of the underlying pathogenetic mechanism in coeliac disease in response to gluten withdrawal.
The HL-A B8 status ofthese patients was studied in relation to the migration index. There is some evidence that the in vitro sensitivity of untreated coeliac mucosa to gluten is dependent upon the presence of the B8 antigen,'6 although we have not confirmed this."1'7 There is also some evidence that the peripheral blood leucocytes of normal controls are more sensitive to gluten if they are from an HL-A B8 positive donor than a non-B8 donor. 6 However, there was no difference in any group of patients between migration indices in B8 positive or negative patients. This finding would be in keeping with our previous results that the in vitro gluten sensitivity of a mucosal biopsy is not enhanced by the possession of the B8 antigen." 17 We have interpreted our results in these experiments in terms of a cell-mediated immune reaction to gluten within untreated coeliac mucosa. It is important to note, however, that other explanations are possible. Leucocyte 20 One way to answer this question in part would be to try to prevent lymphokine production by including a protein synthesis inhibitor in this system. Such an inhibitor is puromycin, which is well demonstrated as inhibiting lymphokine synthesis. [23] [24] [25] We have such experiments under way to try to answer this question.
One final problem is that lymphokines are assumed to be products of T-lymphocytes, but there is evidence that migration inhibition factors can be produced by fibroblast cell culture lines26 or by both T-and B-lymphocytes. 27 It is apparent, therefore, that, despite our assumption that the results in this paper suggest that sensitised lymphocytes within untreated coeliac mucosa produce a leucocyte migration inhibition factor in the presence of GFIII and support the proposal that a cell-mediated immune reaction may be involved in the production ofthe mucosal lesion in coeliac disease, other explanations are possible. 
